Non-stimulant medications like atomoxetine (ATX) have shown similar, albeit somewhat
lower, efficacy and tolerability to stimulants, such as methylphenidate (MPH), in
patients with ADHD. However, their mechanisms of action are not yet well understood.
Critically, both drugs have shown similar beneficial effects on attention symptoms
in patients with ADHD. Despite this, the neurobiological underpinnings of their effect
on attention functions has not been studied previously.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2020 Published by Elsevier Inc.
